Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira ®) in Healthy Adult Japanese Participants
Condition: Healthy Volunteers Interventions: Drug: ABP 501; Drug: Adalimumab Sponsor: Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials